510(k) device
INVISION Total Ankle Revision System
Wrightmedicaltechnologyinc · Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer (HSN, Class II) · First FDA decision Mar 25, 2015, newest Jul 11, 2018Foot and ankle conditions
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
0
Naming "INVISION"
MAUDE reports
106
Brand "INVISION", since 2015
PubMed studies
73
Mentioning "INVISION"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing INVISION Total Ankle Revision System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K180730 · Decided Jul 11, 2018 · 113 days after receipt
Device type: Prosthesis, Ankle, Semi-Constrained, Cemented, Metal/Polymer (HSN) · Orthopedic Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLocal determinationIn effectL37897Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLocal determinationIn effectL37921WPS Insurance CorporationUpdated Nov 20, 2025
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLocal determinationIn effectL37903CGS Administrators, LLCUpdated Jun 11, 2025
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung CancerLocal determinationIn effectL37870Palmetto GBAUpdated Oct 6, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "INVISION", any status and sponsor, newest update first.
No registered device study names "INVISION".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "INVISION", and for the whole product code for context.
This brand
106 reports: 61 malfunction, 44 injury, 0 death
Whole product code HSN
6,457 reports: 216 malfunction, 6,237 injury, 3 death
Newest reports for this brand
MW6003933 · Received Oct 14, 2026 · Event dated Sep 1, 2026
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "INVISION"[tiab]. The summary above synthesizes these.
- Early Survivorship, Clinical and Radiographic Outcomes of a Modular Augmented Revision Total Ankle Arthroplasty System.
Purnell J, Shaffrey I, Ellis S, et al. · Foot Ankle Int · 2024
- The INVISION Talar Component in Revision Total Ankle Arthroplasty: Analysis of Early Outcomes.
Valan B, Anastasio AT, Kim B, et al. · Diagnostics (Basel) · 2024
- Implant Survivorship and Radiographic Outcomes of Revision Total Ankle Arthroplasty Using a Modular Revision System.
Ray JJ, Haynes WB, Graham GD, et al. · Foot Ankle Int · 2025
- Design Rational for Total Ankle Arthroplasty: An Update.
Gross CE, Hsu AR, Scott DJ, et al. · J Am Acad Orthop Surg · 2024
- InVision: An optimized tissue clearing approach for three-dimensional imaging and analysis of intact rodent eyes.
Gurdita A, Nickerson PEB, Pokrajac NT, et al. · iScience · 2021
- Assessment of dronedarone utilization using US claims databases.
Wu J, Thammakhoune J, Dai W, et al. · Clin Ther · 2014
- Prediction of Lymphovascular Space Invision in Endometrial Cancer based on Multi-parameter MRI Radiomics Model.
Wang JJ, Zhang XH, Guo XH, et al. · Curr Med Imaging · 2024
- MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X, Chen Y, Zhao P, et al. · Leuk Lymphoma · 2017Research Support, Non-U.S. Gov't
- A bigura-based real time sentiment analysis of new media.
Xu H · PeerJ Comput Sci · 2024
- Investigation of Stroke Needs (INVISION) Study: Stroke Awareness and Education.
Ing MM, Linton KF, Vento MA, et al. · Hawaii J Med Public Health · 2015Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Photoacoustics resolves species-specific differences in hemoglobin concentration and oxygenation.
Hacker L, Brunker J, Smith ESJ, et al. · J Biomed Opt · 2020Research Support, Non-U.S. Gov't
- The 'Universal Approach' for Dupuytren's disease: A safe and reproducible sequence for planning fasciectomy incisions.
Stoneham A, Fetouh S, Kazzam M, et al. · JPRAS Open · 2024
Other devices of this type
Also filed under product code HSN.
- INFINITY Total Ankle System, INBONE Total Ankle SystemWrightmedicaltechnologyinc · 510(k) 2019
- APEX 3D Total Ankle Replacement SystemParagon 28, Inc. · 510(k) 2025
- The INBONE Total Ankle System, the INFINITY Total Ankle System and the INVISION Total Ankle Revision SystemWrightmedicaltechnologyinc · 510(k) 2020
- Kinos Total Ankle SystemRestor3D · 510(k) 2025
- QUANTUM® Patient Specific Instrumentation (PSI) SystemIn2bones Sas · 510(k) 2024
- restor3d Kinos Axiom Total Ankle SystemRestor3D, Inc. · 510(k) 2024
- Exactech® Vantage® Total Ankle SystemExactech, Inc. · 510(k) 2023
- Vantage® Total Ankle SystemExactech, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.